Lung Cancer Clinical Trial

Molecular and Genetic Analysis of Lung Cancer

Summary

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

View Full Description

Full Description

Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

healthy controls: participants without evidence of any cancer
cases: pathology proven primary lung cancer

Exclusion Criteria:

younger than 18 years old

Study is for people with:

Lung Cancer

Estimated Enrollment:

12000

Study ID:

NCT03029325

Recruitment Status:

Recruiting

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02114, United States More Info
Andrea Shafer, MPH
Contact
617-726-9274

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

12000

Study ID:

NCT03029325

Recruitment Status:

Recruiting

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider